Skip to main content
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ATNM ISIN · US00507W2061 LEI · 549300LCY1NZSXCQDT45 US Manufacturing
Open in API
Filings indexed 493 across all filing types
Latest filing 2014-01-31 Capital/Financing Update
Country US United States of America
Listing US ATNM

About Actinium Pharmaceuticals, Inc.

https://www.actiniumpharma.com/

Actinium Pharmaceuticals, Inc. is a clinical-stage company focused on developing targeted radiotherapies for patients with cancers lacking effective treatment options. The company's platform utilizes potent radioisotopes, such as the alpha-emitter Actinium-225, conjugated to monoclonal antibodies to precisely deliver radiation to cancer cells. Its clinical pipeline addresses hematologic malignancies and solid tumors. Key programs include Iomab-B, a targeted conditioning agent for bone marrow transplant in patients with relapsed or refractory Acute Myeloid Leukemia (AML), and Actimab-A, a CD33-targeting therapy for AML. The company is also advancing ATNM-400, a novel non-PSMA therapeutic for prostate cancer, and developing its proprietary Actinium-225 manufacturing technology and infrastructure.

Recent filings

Filing Released Lang Actions
REGISTRATION STATEMENT
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the company, securities being registered, risk factors, business overview, management discussion and analysis, and financial statements. This type of filing is related to capital raising activities and securities registration, not an annual report, earnings release, or other types of filings. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement of a filing, so it is not RPA or RNS. Hence, the classification is CAP with high confidence.
2014-01-31 English
Regulatory Filings 2014
Regulatory Filings
2014-01-21 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 10, 2014. It details the closing of a private placement of securities, including the sale of common stock and warrants, the gross proceeds raised, and related agreements such as the Registration Rights Agreement and lock-up agreements. The document also references the involvement of a placement agent and the terms of the offering. There are no financial statements or comprehensive financial data included, nor is this an annual or quarterly report. The content focuses on a financing event and capital raising activity. Therefore, this filing is best classified as a Capital/Financing Update (CAP). The document length (6485 characters) and detailed description of the financing terms support this classification with high confidence.
2014-01-13 English
Regulatory Filings 2014
Regulatory Filings
2014-01-07 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated December 27, 2013. It details the completion of a sale of units including common stock and warrants, the gross proceeds received, and related agreements such as the Purchase Agreement, Subscription Agreement, and Registration Rights Agreement. The content focuses on a financing transaction and capital raising event, including details about the securities sold, investor qualifications, and broker dealer fees. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The primary subject is the company's capital raising activity and related agreements. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about the financing event, not just an announcement or summary, so it is not an RPA or RNS. Confidence is high given the clear description of a financing transaction.
2014-01-03 English
CURRENT REPORT
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated December 23, 2013. It details the submission of matters to a vote of security holders at the company's 2013 Annual Meeting of Stockholders. The content includes voting results on director elections, stock plans, amendments to the certificate of incorporation, executive compensation advisory votes, and ratification of the independent registered public accounting firm. The document is focused on reporting the official results of shareholder votes at the Annual Meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not an Annual Report, Proxy Statement, or Management Report, but specifically the voting results from the meeting. The length (7801 characters) and detailed vote counts confirm it is the actual voting results report, not just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2013-12-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.